THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT
AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR
DISSEMINATION IN THE UNITED STATES.


Silvermet Inc. ("Silvermet" or the "Company") (TSX VENTURE:SYI) is pleased to
announce the release of its financial and operating results for Q2, 2011. 


Highlights



--  Operations were cash flow positive and profitable 
    
--  Benefited from reduced smelter treatment charges in Q2, 2011 
    
--  Production increased by 63% to 3,400 DMT from 2,086 DMT in Q2, 2010 (Dry
    Metric Tonnes zinc concentrate containing an average grade of 69% zinc) 
    
--  Average production increased by 63% to 1,133 DMT per month from 695 DMT
    per month in Q2, 2010 
    
--  Sales volumes increased by 17% to 2,772 DMT from 2,372 DMT in Q2, 2010 
    
--  Sales volumes increased by 10% to 6,399 DMT in H1, 2011 from 5,807 DMT
    in H1, 2010 
    
--  Revenues increased by 82% to $3.8 million (at 100%) from $2.1 million in
    Q2, 2010 
    
--  Completed refractory lining change with planned four week shutdown
    spanning March-April 2011.



The following table summarizes comparative quarterly results and reconciles net
earnings, a GAAP measure, to EBITDA. The 2010 figures reflect operational
results at 100% and 2011 figures reflect operational results at a proportionally
consolidated level of 49%.




                                                                            
----------------------------------------------------------------------------
                                        For the three months ended June 30, 
                                  2011              2011               2010 
                                  100%      proportional               100% 
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Gross sales revenues  $      3,833,901  $      1,878,611   $      2,109,494 
                                                                            
Direct operating                                                            
 costs                       1,774,829           832,802          1,977,026 
Treatment &                                                                 
 transportation                970,546           383,609            723,779 
Corporate costs                153,412           153,412            127,447 
----------------------------------------------------------------------------
----------------------------------------------------------------------------
EBITDA(1)             $        935,114  $        508,788   $       (718,758)
----------------------------------------------------------------------------
----------------------------------------------------------------------------
                                                                            
Interest and                                                                
 financing                                        30,560             87,500 
Amortization -                                                              
 Turkey                                           70,806            110,250 
Amortization -                                                              
 Canada                                              990              1,388 
Investment & other                                                          
 gain                                            (60,876)            (1,776)
Foreign exchange                                                            
 loss (gain)                                       4,886           (101,474)
Stock option expense                              24,682             11,873 
Income tax                                        68,045                  - 
Non-controlling interest in net income                                      
 of consolidated affiliates                            -           (488,228)
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Net income (loss) available to common                                       
 shareholders                           $        369,695   $       (338,291)
----------------------------------------------------------------------------
----------------------------------------------------------------------------

                                                                           
---------------------------------------------------------------------------
                                        For the six months ended June 30,  
                                   2011            2011              2010  
                                   100%    proportional              100%  
---------------------------------------------------------------------------
---------------------------------------------------------------------------
Gross sales revenues   $      8,797,305  $    4,310,679  $      6,454,704  
                                                                           
Direct operating                                                           
 costs                        4,086,583       1,917,189         4,489,699  
Treatment &                                                                
 transportation               2,337,016       1,053,179         2,246,141  
Corporate costs                 291,083         291,083           339,750  
---------------------------------------------------------------------------
---------------------------------------------------------------------------
EBITDA(1)              $      2,082,622  $    1,049,228  $       (620,886) 
---------------------------------------------------------------------------
---------------------------------------------------------------------------
                                                                           
Interest and                                                               
 financing                                      204,678           168,969  
Amortization -                                                             
 Turkey                                         135,869           220,537  
Amortization -                                                             
 Canada                                           1,981             3,758  
Investment & other                                                         
 gain                                          (132,957)           (5,017) 
Foreign exchange                                                           
 loss (gain)                                     16,745           (50,492) 
Stock option expense                             52,039            26,560  
Income tax                                      157,477                 -  
Non-controlling                                                            
 interest in net income                                                    
 of consolidated                                                           
 affiliates                                           -          (396,174) 
---------------------------------------------------------------------------
---------------------------------------------------------------------------
Net income (loss)                                                          
 available to common                                                       
 shareholders                            $      613,396  $       (589,027) 
---------------------------------------------------------------------------
---------------------------------------------------------------------------



(1) EBITDA is a non-GAAP measure, does not have a standardized meaning
prescribed by GAAP and may not be comparable to similar terms and measures
presented by other issuers. EBITDA comprises net income (loss) before income
taxes, interest and financing expense (including accretion of liabilities),
amortization expense, gain on dilution, non-controlling interest and stock
option expense. The Company believes it is appropriate to exclude stock option
expense, gain on dilution and non-controlling interest from EBITDA as a measure
of operating performance that excludes non-recurring items.


About Silvermet:

Silvermet's principal business activity is the recycling of electric arc furnace
dust ("EAFD") obtained from steel companies through a Waelz kiln to recover zinc
concentrates that are then sold to zinc smelters throughout the world. The
Company owns 49% of a joint venture, Befesa Silvermet Turkey S.L. ("BST"), which
operates a Waelz kiln facility located in Iskenderun, Turkey.


Caution concerning forward-looking statements: The information in this release
may contain forward-looking information under applicable securities laws. This
forward-looking information is subject to known and unknown risks, uncertainties
and other factors that may cause actual results to differ materially from those
implied by the forward-looking information. Factors that may cause actual
results to vary include, but are not limited to, inaccurate assumptions
concerning the exploration for and development of mineral deposits, political
instability, currency fluctuations, unanticipated operational or technical
difficulties, changes in laws or regulations, the risks of obtaining necessary
licenses and permits, changes in general economic conditions or conditions in
the financial markets and the inability to raised additional financing. Readers
are cautioned not to place undue reliance on this forward-looking information.
The Company does not assume the obligation to revise or update this forward-
looking information after the date of this release or to revise such information
to reflect the occurrence of future unanticipated events except as may be
required under applicable securities laws. The TSX Venture Exchange does not
accept responsibility for the adequacy or accuracy of this release.


Silvermet Inc. (TSXV:SYI)
Historical Stock Chart
Von Mai 2024 bis Jun 2024 Click Here for more Silvermet Inc. Charts.
Silvermet Inc. (TSXV:SYI)
Historical Stock Chart
Von Jun 2023 bis Jun 2024 Click Here for more Silvermet Inc. Charts.